Association of Risk Factor Variables
|
|
- Sharyl McDaniel
- 5 years ago
- Views:
Transcription
1 Association of Risk Factor Variables and Coronary Artery Disease Documented with Angiography DAVID R. HOLMES, JR., M.D., LILA R. ELVEBACK, PH.D., ROBERT L. FRYE, M.D., BRUCE A. KOTTKE, M.D., PH.D., AND RALPH D. ELLEFSON, PH.D. SUMMARY Stepwise linear discrimination was used to analyze risk factors in 431 consecutive patients who underwent coronary angiography to determine which variables were most closely associated with coronary artery disease. Twenty-one risk factors were considered: total plasma cholesterol and triglycerides; the cholesterol and triglyceride content of high-density lipoproteins (HDL), low-density lipoproteins (LDL) and very low density lipoproteins (VLDL); and the percentage of total cholesterol and triglycerides in each fraction. Age, smoking history, family history, hypertension, diabetes mellitus and relative weight were also considered. Coronary artery disease was assessed using three standard grading scores. There were significant differences in risk factors between males and females. In males, LDL cholesterol and age were selected by multivariate analysis. In females, the ratio of HDL cholesterol to total cholesterol, as well as relative weight, family history, age and smoking were selected. The discriminating value of HDL cholesterol as the percentage of total cholesterol was significantly greater than that of HDL cholesterol itself. Despite highly significant associations between risk factors and the presence of coronary artery disease, the discrimination did not provide sufficient separation of the groups to give results that are useful diagnostically in individual patients. THE RELATIONSHIP between hyperlipidemia and an increased risk of coronary heart disease has been well documented and has served as a motivating factor for research into lipoprotein structure, function and metabolism. The aim of the research has been to isolate lipoprotein factors that are most closely associated with coronary heart disease in order to gain some knowledge about the pathophysiology of atherosclerosis and to allow clinicians to identify persons who are at high risk of developing the disease. Although Barr et al.' reported in 1951 the inverse relationship between high-density lipoproteins (HDL) and the incidence of coronary heart disease, until recently most attention has been directed at two of the principal carriers of plasma cholesterol, very low density (VLDL) and low-density (LDL) lipoproteins. During the past several years, however, the importance of HDL has been widely recognized,2 9 and in some studies, HDL appears to have been most predictive of coronary artery disease.10 Those findings support experimental evidence that HDL may have a role in inhibiting the accumulation of cholesterol in arteries by promoting the removal of cellular cholesterol."1-3 Other risk factors, including family history, hypertension, tobacco abuse, age, sex and diabetes also have been found to be associated with an increased risk of coronary artery disease.'4-16 Limited information is available concerning the predictive value From the Division of Cardiovascular Diseases and Internal Medicine, the Section of Medical Research Statistics and the Section of Clinical Chemistry, Mayo Clinic and Mayo Foundation, Rochester, Minnesota. Supported in part by research grant HL-14196, USPHS, NIH. Address for correspondence: D.R. Holmes, Jr., M.D., Mayo Clinic, 200 First Street SW, Rochester, Minnesota Received February 21, 1980; revision accepted June 17, Circulation 63, No. 2, of these variables and their relationship to angiographically defined coronary artery disease.6 ', The purpose of this study was to determine the relationship between angiographically defined coronary artery disease and some of the known risk factors, with specific attention to lipid fractions, and to determine the value of risk factors in predicting the presence of coronary artery disease in patients who undergo coronary angiography. Materials and Methods Four hundred thirty-one consecutive patients (336 males and 95 females) who underwent cardiac catheterization for evaluation of suspected coronary artery disease from 1975 to 1976 were evaluated. Twenty-one independent variables were considered: Total cholesterol;* the cholesterol in VLDL, LDL and HDL; and the ratios of the three fractions to the total; Total triglyceride;* the triglyceride in VLDL, LDL and HDL; and the ratio of the three fractions to the total; Age, relative weight, hypertension (yes or no), smoking (current, past or never), pack-years, diabetes (yes or no), and family history of coronary heart disease.t Coronary angiography was performed by the Judkins or Sones technique. Multiple views of the right and left coronary arteries were recorded. The angiograms were reviewed and coded by two car- *Whole-serum cholesterol and triglyceride were expressed as relative deviates from sex-specific regression of the natural logarithm on age as determined in 458 healthy persons. ta positive history of angina pectoris, myocardial infarction, or sudden abrupt death without obvious qause in the patient's direct blood relatives before age of 55 years. Blood relatives include the patient's parents, siblings, aunts, or uncles related by blood.
2 294 CI RCULATION VOL 63, No 2, FEBRUARY 1981 diologists without knowledge of the patient's lipid levels. The presence and severity of coronary artery disease was determined by consensus. The coronary circulation was divided into 27 segments and the degree of stenosis was coded for each segment. Blood samples were drawn before coronary angiography. Total plasma cholesterol was determined by a semiautomated colorimetric method,20 and triglyceride levels were determined by a semiautomated fluorometric method.20 Lipoprotein electrophoresis and isolation and quantitation of the LDL, VLDL and HDL were performed using techniques previously described The precision of these methods has been verified on blind-duplicate samples. To identify risk factors associated with the presence, severity and extent of coronary artery disease discovered at angiography, three methods were used: (1) stepwise linear discrimination between the two subgroups: those with significant coronary artery disease and those without significant coronary artery disease (i.e., the presence of any segment with > 70% stenosis of the luminal diameter), and (2 and 3) stepwise regression to predict the severity and extent of coronary artery disease, as measured by the Jenkins et al.9 scores and by the Gensini22 scores. Results Characteristics of the Study Group Of the 431 patients, 336 were males and 95 were females. The distributions of the lipids and lipid fractions in the study group are given by sex in table 1. The females had a smaller percentage of current and past smokers (48% vs 81 %) and a higher prevalence of hypertension (52% vs 34%). There were no significant sex differences in the prevalence of diabetes, prior angina or prior myocardial infarction (table 2). Eighty-eight percent of the males had significant coronary artery disease (> 70% luminal narrowing), compared with 63% of the females. The group without significant coronary artery disease was younger and had a lower prevalence of prior angina* and myocardial infarction.t Relationship of Lipids and Results of Arteriography For each sex, the quartiles of the distribution of each of the lipid fractions were determined. For each of these quartiles, the arteriographic results were summarized in terms of the severity of coronary artery disease, as judged by a mean Jenkins score (table 3). In males, the Jenkins score increased by 35% (7.86 to 10.59) from the lowest to the highest quartile of LDL cholesterol. In females, the mean Jenkins score decreased by 59% (8.43 to 3.46) from the lowest to the highest quartile of the ratio of HDL cholesterol to total cholesterol. *The diagnosis of angina pectoris was based on a history of exertional substernal chest discomfort. ta myocardial infarction was considered to have occurred if the patient stated that he had been hospitalized or had been told by his personal physician that he had suffered a myocardial infarction. Stepwise Linear Discrimination (table 4) In males, LDL cholesterol and age were selected as the variables that had significant discriminating power between those with and those without significant coronary artery disease. In addition, total cholesterol and the ratio of LDL cholesterol to total cholesterol were significant on univariate analysis. In males younger than 55 years of age, total cholesterol and pack-years were selected. In this group, as in all males, total cholesterol and LDL cholesterol were essentially tied for first place. In the older group, no variables were significantly associated with the presence of disease. In females, the ratio of HDL cholesterol to total cholesterol was the first variable selected; also selected were age, smoking, relative weight and family history. Seven other variables were significant by univariate methods, and of these, the first was the ratio of HDL triglyceride to total triglyceride, which was positively correlated with the ratio of HDL cholesterol to total cholesterol (r = 0.51). The ratio of HDL cholesterol to total cholesterol was of major importance in both female age groups. In those younger than 55 years, this ratio was essentially equal with family history, which was selected as the first variable. Smoking was the third variable. Pack-years and the ratio of HDL triglyceride to total triglyceride also were significant (p < 0.01). In women age 55 years or older, the ratio of HDL cholesterol to total cholesterol and relative weight were selected. No other variables were significant. The results of the stepwise regression for the Jenkins et al.9 and Gensini22 severity and extent scores reproduced those given above, except for minor differences in the ordering of variables. In females, the discriminating value of HDL cholesterol expressed as a percentage of total cholesterol was much greater than that of the HDL cholesterol concentration itself. The significance level for the ratio was < 0.001, compared with the concentration itself, which was of only borderline significance (p < 0.05). Even with the use of the ratio of HDL cholesterol to total cholesterol, there was considerable overlap between females with and without disease (fig. 1). In males, HDL did not discriminate between those with and those without disease. Even with the use of LDL, the overlap between males with and without disease was considerable (fig. 1). While the discriminant functions served to separate the mean scores for subjects with and without significant coronary disease, the overlap in the distributions was substantial, and only 65% of the males and 76% of the females could be classified correctly (fig. 2). Discussion Since an association of cholesterol and the development of atherosclerosis was recognized in 1913,23 an association of lipoprotein abnormalities and ischemic heart disease has been well documented. Although LDL cholesterol, total cholesterol and total triglyceride levels are directly related to prevalence of coronary artery disease, HDL cholesterol has been
3 RISK FACTORS AND CAD/Holmes et al. 295 TABLE 1. Distribution of Lipids and Lipid Fractions (mg/dl) in the Study Group Percentiles of the distribution Range P10 P25 P50 P75 P90 Cholesterol Total M* F* HDL M F LDL M F VLDL M F Triglyceride Total M F HDL M F LDL M F VLDL M F *M = 336; F 95. Abbreviations: HDL density lipoprotein. high-density lipoprotein; LDL low-density lipoprotein; VLDL - very low TABLE 2. Characteristics of the Study Group of Patients Undergoing Coronary Angiography Males Females <707O * >70%* <70%* >70%* (n= 40) (n= 296) (n= 35) (n= 60) Characteristic No. % No. % No. % No. % Age (years) < HistorY of angina History of myocardial infarction History of diabetes History of hypertension Family history Smoking CUrrent Past Never *ReferS to maximal stenosis.
4 296 CIRCULATION VOL 63, No 2, FEBRUARY 1981 TABLE 3. LDL chol HDL chol HDL chol/total chol VLDL chol Trig total LDL trig HDL trig Jenkins Angiography Score for Quartiles of the Lipid Distributions by Sex Lipid Q_ Q2 Q4 Q3 Mean SEM Mean SEM Mean SEM Mean SEM Chol total M F M F m F M F M F M F M F M F a VLDL trig M F Abbreviations: Chol - cholesterol, LDL = low-density VLDL very low density lipoprotein; Trig - triglyceride. X.tJ9 U a a lipoprotein; HDL = high-density lipoprotein; TABLE 4. Results of Stepwise Linear Discrimination and Univariate Analysis of Risk Factors in Patients Undergoing Coronary Angiography Males Females <55 >55 <55 >55 Total years years Total years* years* Patients Patients with > 70,rC. st.enosis of coronary arteries Variables selected by LDL Total None R-C-HI)L Family R-C-HDL stepwise linear cholesterol cholesterol history discrimnination Age Pack-years Relative weight Smoking Relative Age Family history Smoking weight Additional variables Total LDL None R-T-HDL R-C-HDL None significant (p < 0.05) cholesterol cholesterol on univariate analysis R-C-LDL R-T-VLDL Relative Total triglyceride weight LDL triglyceride Pack-years HDL cholesterol Total LDL cholesterol cholesterol VLDL cholesterol *Because of the few females, only the five variables selected for the total female group were used in the two age groups. Abbreviations: LI)L = low-density lipoprotein; HDL = high-density lipoprotein; VLDL = very low density lipoprotein; R-C-HDL or R-C-LDL = ratio of fraction to total cholesterol; R-T-HDL or R-T-VLDL ratio of fraction to total triglyceride.
5 RISK FACTORS AND CAD/Holmes et al. 297 Q J (D C.. 0) Females A /\ > 70% 1 %X "-- < 70% 1, 1 30[ 201 io0 336 Males - '70% n= <70% n= ua) CL ti N l HDL-chol/total chol x 100 Males - >70% ---<70% LDL chol (mg/dl) FIGURE 1. Distribution of ratio of high-density lipoprotein cholesterol (HDL chol) to total cholesterol (percent) for 60 females with maximal stenosis > 70% and 35 with maximal stenosis < 70%, and distribution of low-density lipoprotein cholesterol (LDL chol) in 295 males with maximal stenosis 70% and 39 with maximal stenosis < 70%. found to be more closely associated.2 An inverse association between HDL cholesterol and coronary artery disease persists even when adjusted for LDL cholesterol and triglyceride levels.2 Some investigators have found that the HDL cholesterol level correlates with the extent and severity of coronary artery disease9 and may be correlated with specific anatomic patterns.5 Although the total HDL cholesterol is better in predicting coronary artery disease than total cholesterol, some authors have found that the ratio of HDL cholesterol to total cholesterol may be even more useful.3 6 In our population, there were significant differences between males and females in regard to lipid fractions most closely associated with coronary artery disease. In females, the best correlation was the ratio of HDL cholesterol to total cholesterol, which was significantly better than the HDL cholesterol level itself. This was true in both age groups when either a continuous variable (that is, extent and severity of coronary artery disease) or the dichotomous variable (the presence or absence of coronary artery disease) was used as an end point. Seven additional lipid fractions were significant in univariate analysis, including HDL cholesterol and LDL cholesterol (table 4). In 0 CL i_ 95 Females ' 70% n % n-35 \, X/ 1 I Discriminant score FIGURE 2. Discriminant function scores for males and females with and without coronary artery disease. For males, the score is based on age and low-density lipoprotein cholesterol, for females, the score is based on R-C-HDL (ratio of high-density lipoprotein fraction to total cholesterol), relative weight, age, family history of coronary artery disease and smoking. males, the only lipid variable selected was LDL cholesterol, although total cholesterol and the ratio of LDL cholesterol to total cholesterol were significant on univariate analysis. This was also most significant regardless of whether the end point was the presence or absence of coronary artery disease or the extent and severity of coronary artery disease. In contradistinction to the results in women, we could not identify any significant risk factors in men age 55 years or older. This may indicate that aging and sex are such powerful risk factors that they "wash out" the effect of the other variables.24 In contrast to the findings of some other investigators,5' 9 we found no significant relationship between HDL cholesterol and coronary artery disease in males. In contrast to Pearson et al.,5 who found that low levels of HDL cholesterol were associated with left main coronary artery disease, we found that the risk factors associated with left main coronary artery disease were similar to the variables associated with coronary artery disease as a whole, that is, LDL cholesterol and age. The reasons for these differences are unclear but may relate to different patient populations. The mode of action of HDL is not fully understood. Biochemical studies have shown that the body
6 298 CI RCULATION VOL 63, No 2, FEBRUARY 1981 cholesterol pool is negatively correlated with the concentration of plasma HDL cholesterol.'1 Miller and Millerll and Stein et al.13 suggested that HDL cholesterol facilitates the removal of intracellular cholesterol from nonhepatic tissue and functions as a transport vehicle, returning the cholesterol to the liver for catabolism and excretion. HDL also might inhibit the entrance of LDL into cells by competitive binding with the LDL receptors.'3 Either mechanism may have an important role in the development of atherosclerosis. While the entry of cholesterol into the cells is facilitated by the binding of LDL to surface receptors,25 the rate of LDL uptake is regulated by the cellular content of cholesterol. Homeostasis of cellular cholesterol seems to be maintained by a balance between uptake and removal mechanisms, and in turn, the cellular level of cholesterol appears to influence cellular cholesterol synthesis. The relationships among LDL binding, cholesterol uptake, cholesterol transfer to HDL from cells, LDL levels and dynamics, HDL levels and dynamics, and cholesterol biosynthesis all may be significant in the development of atherosclerosis.25' 26 In addition to differences between males and females in lipid fractions most closely associated with coronary artery disease, there were also sex-related differences in the other risk factors. In both young males and females, smoking history also was selected on linear regression. This is similar to other reported series, which have documented that the younger the age group, the higher the risk associated with smoking.24', 2 28 The other variables selected with linear regression in the females were family history, relative weight and age. In the younger age group, the family history of early onset of arteriosclerotic heart disease was the strongest variable. This supports evidence that has demonstrated an increased risk of coronary artery disease in relatives of people who have the onset of coronary artery disease at an early age Patients with positive family histories were younger and had higher cholesterol levels and lower ratios of HDL cholesterol to total cholesterol. Hypertension has been found to be an important risk factor for the development and prognosis of coronary artery disease. The fact that hypertension does not seem to discriminate at the angiographic level in this and other studies18 may be due to the weakness of the measure used, that is, a history of the presence or absence of hypertension. If we could measure the total impact in terms of the duration and degree of elevation of the blood pressure, the presence of hypertension might well be found to be more significant. Studies on the association of risk factors and coronary artery disease have used several different markers of the disease. Some of those have had significant limitations. Those studies based on the clinical diagnosis of coronary artery disease have been by their very design limited because certain patient populations, for example women, may have clinical coronary artery disease with angina pectoris without having angiographically demonstrable coronary artery disease. More recent studies that have used coronary angiography to define the population samples have solved this problem but still have had limitations. The use of dichotomous variables such as stenosis of less than 70% and of 70% or more in identifying those factors associated with the presence and severity of coronary artery disease has some potential problems. These can be avoided by using a continuous variable end point; for example, scores that consider both the severity and extent of disease. In our study, however, the significant risk factors were similar, regardless of which coronary score was used. Risk factor studies in a population that undergoes coronary arteriography have the advantage that the major proportion of the misclassification present in clinically diagnosed series is clearly defined and provides a comparison group. This advantage, however, is offset by the complex and largely undefined process by which the study group is selected. The angiographic group, as well as the subset in which no coronary artery disease is found is not representative of the population at large. The selection process that results in a population that undergoes coronary angiography may significantly alter (intensify or dilute) the associations in the population as a whole between coronary artery disease and various risk factors. Even in our angiographic series, although highly significant relationships were found, they were not clinically useful at the level of an individual patient in predicting coronary artery disease. References 1. Barr DP, Russ EM, Eder HA: Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. Am J Med 11: 480, Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ: HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phenotyping Study. Circulation 55: 767, Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 62: 707, Gofman JW, Young W, Tandy R: Ischemic heart disease, atherosclerosis, and longevity. Circulation 34: 679, Pearson TA, Bulkley BH, Achuff SC, Kwiterovich PO, Gordis L: The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol 109: 285, Williams P, Robinson D, Bailey A: High-density lipoprotein and coronary risk factors in normal men. Lancet 1: 72, Miller NE, Forde OH, Thelle DS, Mjos OD: The Troms0 heart-study: high-density lipoprotein and coronary heartdisease; a prospective case-control study. Lancet 1: 965, Ononogbu IC: High density lipoproteins in ischaemic heart disease. Experientia 33: 1063, Jenkins PJ, Harper RW, Nestel PJ: Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J 2: 388, Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women: The Framingham Study. Ann Intern Med 87: 393, Miller GJ, Miller NE: Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1: 16, Carew TE, Koschinsky T, Hayes SB, Steinberg D: A mecha-
7 RISK FACTORS AND CAD/Holmes et al. 299 nism by which high-density lipoproteins may slow the atherogenic process. Lancet 1: 1315, Stein Y, Glangeaud MC, Fainaru M, Stein 0: The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein. Biochim Biophys Acta 380: 106, Reid DD, Hamilton PJS, McCartney P, Rose G, Jarrett RJ, Keen H: Smoking and other risk factors for coronary heartdisease in British civil servants. Lancet 2: 979, Rosenman RH, Brand RJ, Sholtz RI, Friedman M: Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaboration Group Study. Am J Cardiol 37: 903, Gordon T, Sorlie P, Kannel WB: Coronary heart disease, atherothrombotic brain infarction, intermittent claudicationa multivariate analysis of some factors related to their incidence: Framingham Study, 16-year followup. In The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, edited by Kannel WB, Gordon T. Washington DC, US Govt Printing Off, 1971, Section Frick MH, DahWn G, Berg K, Valle M, Hekali P: Serum lipids in angiographically assessed coronary atherosclerosis. Chest 73: 62, Anderson AJ, Barboriak JJ, Rimm AA: Risk factors and angiographically determined coronary occlusion. Am J Epidemiol 107: 8, Welch CC, Proudfit WL, Sheldon WC: Coronary arteriographic findings in 1,000 women under age 50. Am J Cardiol 35: 211, Ellefson RD, Caraway WT: Lipids and lipoproteins. In Fundamentals of Clinical Chemistry, edited by Tietz NW. Philadelphia, WB Saunders Company, 1976, pp Ellefson RD, Elveback LR, Hodgson PA, Weidman WH: Cholesterol and triglycerides in serum lipoproteins of young persons in Rochester, Minnesota. Mayo Clin Proc 53: 307, Gensirti GG. Coronary Arteriography. Mount Kisco, New York, Futura Publishing Company, 1975, pp Anitschkow N, Chalatow S: Ueber experimentelle Cholesterinsteatose und ihre Bedeutung for die Entstehung einiger pathologischer Prozesse. Zentralbl AlIg Pathol 24: 1, Vlietstra RE, Frye RL, Kronmal RA, Sim DA, Tristani FE, Killip T III: Risk factors and angiographic coronary artery disease: a report from the Coronary Artery Surgery Study (CASS). Circulation 62: 254, Goldstein JL, Brown MS: The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 46: 897, Small DM: Cellular mechanisms for lipid deposition in atherosclerosis. N EngI J Med 297: 873, Hammond EC: Smoking in relation to the death rates of one million men and women. Nat Cancer Inst Monogr 19: 127, Hammond EC, Garfinkel L: Coronary heart disease, stroke, and aortic aneurysm: factors in the etiology. Arch Environ Health 19: 167, Epstein FH: Risk factors in coronary heart disease: environmental and hereditary influences. Isr J Med Sci 3: 594, Bloor CM: Hereditary aspects of myocardial infarction. Circulation 40 (suppl IV): IV-130, Bloor CM, McKusick VA: The genetics of coronary artery disease. In Symposium on Coronary Heart Disease, 2nd ed, edited by Blumgart HL. Dallas, American Heart Association, 1968, monograph no. 2, pp 6-11
High Density Lipoprotein Cholesterol and Mortality
High Density Lipoprotein Cholesterol and Mortality The Framingham Heart Study Peter W.F. Wilson, Robert D. Abbott, and William P. Castelli In 12 years of follow-up for 2748 Framingham Heart Study participants
More informationCHOLESTEROL AND CORONARY ARTERY DISEASE: AGE AS AN EFFECT MODIFIER
CHOLESTEROL AND CORONARY ARTERY DISEASE: AGE AS AN EFFECT MODIFIER By: Steven J. Jacobsen, David S. Freedman, Raymond G. Hoffmann, Harvey W. Gruchow, Alfred J. Anderson, and Joseph J. Barboriak Jacobsen
More informationLow fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease
(2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk
More informationEpidemiologic and clinical comparison of renal artery stenosis in black patients and white patients
ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,
More informationAlcohol Consumption and the Diet-Heart Controversy. By: Joseph J. Barboriak, ScD, Harvey W. Gruchow, PhD, and Alfred J.
Alcohol Consumption and the Diet-Heart Controversy By: Joseph J. Barboriak, ScD, Harvey W. Gruchow, PhD, and Alfred J. Anderson, MS Barboriak JJ, Gruchow HW, and Anderson AJ: Alcohol consumption and the
More informationIntermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis
Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which
More informationThe investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India
eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,
More informationDiabetologia 9 Springer-Verlag 1991
Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease
More informationHDL Cholesterol and Other Lipids
HDL Cholesterol and Other Lipids in Coronary Heart Disease The Cooperative Lipoprotein Phenotyping Study WILLIAM P. CASTELLI, M.D., JOSEPH T. DOYLE, M.D., TAVIA GORDON, CURTIS G. HAMES, M.D., MARTHANA
More informationHigh density lipoprotein cholesterol and longevity.
Journal of Epidemiology and Community Health, 1987, 42, 60-65 High density lipoprotein cholesterol and longevity. ANCEL KEYS From the Division of Epidemiology, School of Public Health, University of Minnesota,
More informationComparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study
80 Comparison of Probability of Stroke Between the Copenhagen City Heart Study and the Framingham Study Thomas Truelsen, MB; Ewa Lindenstrtfm, MD; Gudrun Boysen, DMSc Background and Purpose We wished to
More informationThe Speedwell study. Prevalence of ischaemic heart disease and associations. with serum lipoproteins in subjects aged 45 to 64 years
Br Heart J 1982; 47: 483-9 Prevalence of ischaemic heart disease and associations with serum lipoproteins in subjects aged 45 to 64 years The Speedwell study D BAINTON, C J BURNS-COX, P C ELWOOD, B LEWIS,
More informationEFFECT OF NICARDIPINE ON FASTING PLASMA LIPIDS AND APOLIPOPROTEINS IN MALE NEW ZEALAND WHITE RABBITS. Kamsiah Jaarin, Nafeeza MI*
REVIEW ARTICLE Malaysian Journal of Medical Sciences, Vol. 6, No. 2, July 1999 (5-11) EFFECT OF NICARDIPINE ON FASTING PLASMA LIPIDS AND APOLIPOPROTEINS IN MALE NEW ZEALAND WHITE RABBITS Kamsiah Jaarin,
More informationRisk Factors for Ischemic Stroke: Electrocardiographic Findings
Original Articles 232 Risk Factors for Ischemic Stroke: Electrocardiographic Findings Elley H.H. Chiu 1,2, Teng-Yeow Tan 1,3, Ku-Chou Chang 1,3, and Chia-Wei Liou 1,3 Abstract- Background: Standard 12-lead
More informationHigh density lipoprotein cholesterol (HDL-C) analysis in leprosy patients
Lepr Rev (1984) 55, 167-171 High density lipoprotein cholesterol (HDL-C) analysis in leprosy patients V SRITHARAN,* V P BHARADWAJ,t K VENKATESAN,t B K GIRDHARt & K v DESIKANt * Department of Biochemistry,
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationTitle for Paragraph Format Slide
Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38
More informationHow would you manage Ms. Gold
How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56
More informationHIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES
HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused
More informationRisks of mild hypertension: a ten-year report
British HeartJournal, I971 33, Supplement, II6-I2I. Risks of mild hypertension: a ten-year report Oglesby Paul' From the Participating Centers in the Pooling Project of the Council on Epidemiology of the
More informationThe importance of both low-density lipoprotein
Improving the Prediction of Cardiovascular Risk: Interaction Between LDL and HDL Cholesterol Steven A. Grover, 1,2,3,4 Marc Dorais, 1,3 and Louis Coupal 1,3 Background. The ratio of total cholesterol to
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationCurrent Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD
Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center
More informationLow-density lipoprotein as the key factor in atherogenesis too high, too long, or both
Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both Lluís Masana Vascular Medicine and Metabolism Unit. Sant Joan University Hospital. IISPV. CIBERDEM Rovira i Virgili
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More informationCoronary arteriographic study of mild angina
British HeartJournal, I975, 37, 752-756. Coronary arteriographic study of mild angina W. Walsh, A. F. Rickards, R. Balcon From the National Heart Chest Hospitals, London Chest Hospital, London The results
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationFasting or non fasting?
Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics Which is best to measure Lower continues
More informationUpdate on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines
Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease
More informationCho et al., 2009 Journal of Cardiology (2009), 54:
Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal
More informationNew Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines
Clin. Cardiol. Vol. 26 (Suppl. III), III-19 III-24 (2003) New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines H. BRYAN BREWER, JR, M.D. Molecular
More informationPattern of plasma lipoprotein (a) in Sudanese patients with coronary
Pattern of plasma lipoprotein (a) in Sudanese patients with coronary artery disease Mansour Eltahir Farah 1, Khairia Eltahir Abdullah 2, Huda HM Elhassan 3, Mohammed O EH Gadour 1, Mohammed Saeed Alkhaleefa
More informationDivision of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan
Association between continuously elevated C-reactive protein and restenosis after percutaneous coronary intervention using drug-eluting stent in angina patients Division of Cardiovascular Medicine, Jichi
More informationLipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures
Lipoprotein (a): Should We Measure? Should We Treat? Joseph P. McConnell, Ph.D. DABCC Health Diagnostic Laboratory Inc. Baptist Health South Florida Eleventh Annual Cardiovascular Disease Prevention International
More informationCoronary artery disease (CAD) risk factors
Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More information(LDL) which are implicated in the pathogenesis of
Brit J. Sports Med. - Vol. 14, No. 4, December 1980, pp. 19-4 D. Donaldson R. C. Kester HIGH DENSITY LIPOPROTEINS AND EXERCISE D. R. DONALDSON, BSc, FRCS, (Registrar) and R. C. KESTER, MD, ChM, FRCS (Senior
More informationThe Second Report of the Expert Panel on Detection,
Blood Cholesterol Screening Influence of State on Cholesterol Results and Management Decisions Steven R. Craig, MD, Rupal V. Amin, MD, Daniel W. Russell, PhD, Norman F. Paradise, PhD OBJECTIVE: To compare
More informationDisclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017
Disclosures MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES Grants: NIH, Quest Diagnostics Consultant: Quest Diagnostics Merck Global Atherosclerosis Advisory Board Ronald M. Krauss, Children s Hospital
More informationWho Cares About the Past?
Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring
More informationnormocholesterolaemic, non-diabetic Indian men with
Postgrad Med J (1991) 67, 159-164 i The Fellowship of Postgraduate Medicine, 1991 Serum lipoproteins and apolipoproteins in young normocholesterolaemic, non-diabetic Indian men with myocardial infarction
More informationEmmanouil S. Brilakis 1{, Joseph P. McConnell 2, Ryan J. Lennon 3, Ahmad A. Elesber 1, Jeffrey G. Meyer 2, and Peter B. Berger 4 * Introduction
European Heart Journal (2005) 26, 137 144 doi:10.1093/eurheartj/ehi010 Clinical research Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic
More informationImpact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease
Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,
More informationCoronary artery occlusion and alcohol intake
British Heart journal, 1977, 39, 289-293 Coronary artery occlusion and alcohol intake JOSEPH J. BARBORIAK, ALFRED A. RIMM, ALFRED J. ANDERSON, MARK SCHMIDHOFFER, AND FELIX E. TRISTANI From the Research
More informationRelation of Extent of Extracranial Carotid Artery Atherosclerosis as Measured by B-Mode Ultrasound to the Extent of Coronary Atherosclerosis
786 Relation of Extent of Extracranial Carotid Artery Atherosclerosis as Measured by B-Mode Ultrasound to the Extent of Coronary Atherosclerosis James L. Wofford, Frederic R. Kahl, George R. Howard, William
More informationSerum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease
Serum Creatinine and Blood Urea Nitrogen Levels in Patients with Coronary Artery Disease MAK Akanda 1, KN Choudhury 2, MZ Ali 1, MK Kabir 3, LN Begum 4, LA Sayami 1 1 National Institute of Cardiovascular
More informationSupplementary Note Details of the patient populations studied Strengths and weakness of the study
Supplementary Note Details of the patient populations studied TVD and NCA patients. Patients were recruited to the TVD (triple vessel disease) group who had significant coronary artery disease (defined
More informationPrognostic importance of exercise-induced ST-segment depression in patients with documented coronary artery disease
European Heart Journal (1987) 8 (Supplement G), 109-113 Prognostic importance of exercise-induced ST-segment depression in patients with documented coronary artery disease H. GOHLKE, P. BETZ AND H. ROSKAMM
More informationQ. Qiao 1, M. Tervahauta 2, A. Nissinen 2 and J. Tuomilehto 1. Introduction
European Heart Journal (2000) 21, 1621 1626 doi:10.1053/euhj.2000.2151, available online at http://www.idealibrary.com on Mortality from all causes and from coronary heart disease related to smoking and
More informationRelation of Saphenous Vein Graft Obstruction to Serum Cholesterol Levels
JACC Vol. 25, No. 1 193 Janua~ 1995:193-7 Relation of Saphenous Vein Graft Obstruction to Serum Cholesterol Levels HIROYUKI DAIDA, MD, HISASHI YOKOI, MD, HIROSHI MIYANO, MD, HIROSHI MOKUNO, MD, HIROYUKI
More informationCOMPARISON OF LIPID PROFILE IN DIABETIC AND NON DIABETIC MALE AND FEMALE BELOW AND ABOVE THE 45 YEARS OF AGE GROUP
8 COMPARISON OF LIPID PROFILE IN DIABETIC AND NON DIABETIC MALE AND FEMALE BELOW AND ABOVE THE 45 YEARS OF AGE GROUP *DR OMNATH PRASAD YADAV, **DR HITESHKUMAR K SOLANKI, ***DR KRISHNA SINGH, ****DR N P
More informationPage 1. Disclosures. Background. No disclosures
Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen
More informationSUPPLEMENTAL MATERIAL. Materials and Methods. Study design
SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants,
More informationAmerican Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease
American Medical Women s Association Position Paper on Principals of Women & Coronary Heart Disease AMWA is a leader in its dedication to educating all physicians and their patients about heart disease,
More informationWhat s New in the Management of Peripheral Arterial Disease
What s New in the Management of Peripheral Arterial Disease Sibu P. Saha, MD, MBA Professor of Surgery Chairman, Directors Council Gill Heart Institute University of Kentucky Lexington, KY Disclosure My
More informationBehind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL
Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:
More informationThe purpose of this report is to compare the results of
Comparison of Two Measures of Atherosclerosis in a Prospective Epidemiology Study Dwayne M. Reed, Jack P. Strong, Takuji Hayashi, W. P. ewman III, Richard E. Tracy, Miguel A. Guzman, and Grant. Stemmermann
More informationClinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease
Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon
More informationPlasma lipids can be reliably assessed within 24 hours after
Postgraduate Medical Journal (1988) 64, 352-356 Plasma lipids can be reliably assessed within 24 hours after acute myocardial infarction M. Sewdarsen, S. Vythilingum, I. Jialal* and R. Nadar Ischaemic
More informationOriginal Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit
98 Original Contributions Prospective Comparison of a Cohort With Carotid Bruit and a Population-Based Cohort Without Carotid Bruit David O. Wiebers, MD, Jack P. Whisnant, MD, Burton A. Sandok, MD, and
More informationCETP inhibition: pros and cons. Philip Barter The Heart Research Institute Sydney, Australia
CETP inhibition: pros and cons Philip Barter The Heart Research Institute Sydney, Australia Philip Barter Disclosures Received honorariums for lectures, consultancies or membership of advisory boards from:
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationCoronary artery disease in twins
DAVID R HOLMES JR, ARTHUR J KENNEL, HUGH C SMITH, HYMIE GORDON, S BREANNDAN MOORE Br Heart J 1981; 45: 193-7 From the Division of Cardiovascular Diseases and Internal Medicine, the Division of Community
More informationwith Vasospastic Angina
Original Article tudy on Lipid and Glucose Metabolism in Patients with Vasospastic Angina Hisashi YOSHIDA, Keiji MURAKAMI and Goro MlMURA The primary purpose of the present study was to evaluate the role
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationThe inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema
The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,
More informationinsulin, lipid and lipoprotein levels in twenty-five patients suffering from peripheral arterial disease. Subjects
Postgraduate Medical Journal (July 1972) 48, 409-413. The effect of fenfluramine on glucose tolerance, insulin, lipid and lipoprotein levels in patients with peripheral arterial disease B. P. BLISS M.S.,
More informationThe TNT Trial Is It Time to Shift Our Goals in Clinical
The TNT Trial Is It Time to Shift Our Goals in Clinical Angioplasty Summit Luncheon Symposium Korea Assoc Prof David Colquhoun 29 April 2005 University of Queensland, Wesley Hospital, Brisbane, Australia
More informationCorrelation of LV Longitudinal Strain by 2D Speckle Tracking with Cardiovascular risk in Elderly. (A pilot study of EGAT-Echo study.
Correlation of LV Longitudinal Strain by 2D Speckle Tracking with Cardiovascular risk in Elderly. (A pilot study of EGAT-Echo study.) Researcher: Dr. Atthakorn Wutthimanop, MD. Research adviser: Dr.PrinVathesathokit,
More informationComparison of Original and Generic Atorvastatin for the Treatment of Moderate Dyslipidemic Patients
Comparison of Original and Generic Atorvastatin for the Treatment of Moderate Dyslipidemic Patients Cardiology Department, Bangkok Metropolitan Medical College and Vajira Hospital, Bangkok, Thailand Abstract
More informationORIGINAL CONTRIBUTION. Risk of Developing Coronary Artery Disease Following a Normal Coronary Angiogram in Middle-Aged Adults
ORIGINAL CONTRIBUTION Risk of Developing Coronary Artery Disease Following a Normal Coronary Angiogram in Middle-Aged Adults Maheswara S.G. Rao Golla, MBBS 1 ; Timir Paul, MD 2 ; Siddhartha Rao, MD 1 ;
More informationLipids Testing
190.23 - Lipids Testing Lipoproteins are a class of heterogeneous particles of varying sizes and densities containing lipid and protein. These lipoproteins include cholesterol esters and free cholesterol,
More informationThe Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease. William E. Feeman, Jr., M.D.
The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease William E. Feeman, Jr., M.D. 640 South Wintergarden Road Bowling Green, Ohio 43402 Phone 419-352-4665 Fax
More informationDeclaration of conflict of interest. None to declare
Declaration of conflict of interest None to declare Risk management of coronary artery disease Arrhythmias and diabetes Hercules Mavrakis Cardiology Department Heraklion University Hospital Crete, Greece
More informationData Alert. Vascular Biology Working Group. Blunting the atherosclerotic process in patients with coronary artery disease.
1994--4 Vascular Biology Working Group www.vbwg.org c/o Medical Education Consultants, LLC 25 Sylvan Road South, Westport, CT 688 Chairman: Carl J. Pepine, MD Eminent Scholar American Heart Association
More informationHigh Sensitive C-Reactive Protein (hs-crp) and its Correlation with Angiographic Severity of Coronary Artery Disease (CAD)
ORIGINAL ARTICLE JIACM 2007; 8(3): 217-21 High Sensitive C-Reactive Protein (hs-crp) and its Correlation with Angiographic Severity of Coronary Artery Disease (CAD) Tenzin Nyandak*, Arun Gogna**, Sandeep
More informationApplicability of Cholesterol-Lowering Primary Prevention Trials to a General Population
Applicability of Cholesterol-Lowering Primary Prevention Trials to a General Population The Framingham Heart Study ORIGINAL INVESTIGATION Donald M. Lloyd-Jones, MD; Christopher J. O Donnell, MD, MPH; Ralph
More informationJournal of the American College of Cardiology Vol. 42, No. 6, by the American College of Cardiology Foundation ISSN /03/$30.
Journal of the American College of Cardiology Vol. 42, No. 6, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00922-7
More informationPCSK9 Inhibition: From Genetics to Patients
PCSK9 Inhibition: From Genetics to Patients John Chapman BSc, Ph.D., D.Sc., FESC Research Professor, University of Pierre and Marie Curie Director Emeritus, INSERM Dyslipidemia and Atherosclerosis Research
More informationLipids Testing
Previously Listed as Edit 12 190.23 - Lipids Testing Lipoproteins are a class of heterogeneous particles of varying sizes and densities containing lipid and protein. These lipoproteins include cholesterol
More informationpresence or absence of CAD needs to be critically examined.
Lipoproteins in Patients with Proved Coronary Artery Disease: Qualitative and Quantitative Changes in Agarose-gel Electrophoretic Patterns ROBERT C. BAHLER, M.D., JAN J. OPPLT, M.D., PH.D., AND DAVID M.
More informationCommon Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2
Established CVD Common Repatha Documentation Requirements for Patients With Primary Hyperlipidemia and Established CVD 1,2 Primary and Secondary Diagnosis Codes Primary Diagnosis: Primary hyperlipidemia
More informationTreatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center
Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment
More informationStudy of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease
Original article: Study of serum Lipid Profile patterns of Indian population in young Ischaemic Heart Disease Dr Sonu Yadav, Dr Abhijit Nikam, Dr Vivek Chiddarwar, Dr A L Kakrani Department of Medicine,
More informationCardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az
Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of
More informationChronic Benefit Application Form Cardiovascular Disease and Diabetes
Chronic Benefit Application Form Cardiovascular Disease and Diabetes 19 West Street, Houghton, South Africa, 2198 Postnet Suite 411, Private Bag X1, Melrose Arch, 2076 Tel: +27 (11) 715 3000 Fax: +27 (11)
More informationYOUR INFORMATION. Ischemic Heart Disease
YOUR INFORMATION Ischemic Heart Disease ISCHEMIC HEART DISEASE Your diagnosis You have been given a diagnosis of heart failure, which usually means your heart is working inefficiently. This inefficiency
More informationCoronary Artery Disease in Diabetic and Nondiabetic Patients: A Clinical and Angiographic Comparison
Clin. Cardiol. 6,44-446 (1983) Clinical Cardiology Publishing Co., Inc. Coronary Artery Disease in Diabetic and Nondiabetic Patients: A Clinical and Angiographic Comparison c. s. WILSON, M.D., F.A.c.c.*~,
More informationFinancial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017
Coronary Artery Calcification Dharmendra A. Patel, MD MPH Director, Echocardiography Laboratory Associate Program Director Cardiovascular Disease Fellowship Program Erlanger Heart and Lung Institute UT
More informationCombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women
European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular
More informationDIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN
DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and
More informationKidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain)
Kidney and heart: dangerous liaisons Luis M. RUILOPE (Madrid, Spain) Type 2 diabetes and renal disease: impact on cardiovascular outcomes The "heavyweights" of modifiable CVD risk factors Hypertension
More informationThe Whitehall II study originally comprised 10,308 (3413 women) individuals who, at
Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.
More informationMeasurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Original Policy Date
MP 2.04.22 Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with
More informationRisk Factors and Primary and Secondary Prevention of Coronary Heart Disease
Special Issue Risk Factors and Primary and Secondary Prevention of Coronary Heart Disease Shung Chull Chae, M.D. Department of Internal Medicine / Division of Cardiology Kyungpook National University College
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationDiabetologia 9 Springer-Verlag 1981
Diabetologia (1981) 20:535-539 Diabetologia 9 Springer-Verlag 1981 High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels at Diagnosis in Patients with Non-Insulin Dependent Diabetes K. G.
More informationHeart Disease. Signs and Symptoms
Heart Disease The term "heart disease" refers to several types of heart conditions. The most common type is coronary artery disease, which can cause heart attack, angina, heart failure, and arrhythmias.
More information